Compare · GDRX vs INFY
GDRX vs INFY
Side-by-side comparison of GoodRx Holdings Inc. (GDRX) and Infosys Limited (INFY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GDRX and INFY operate in EDP Services (Technology), so they compete in similar markets.
- INFY is the larger of the two at $51.01B, about 57.3x GDRX ($890.7M).
- Over the past year, GDRX is down 36.0% and INFY is down 32.7% - INFY leads by 3.3 points.
- INFY has been more active in the news (11 items in the past 4 weeks vs 3 for GDRX).
- Both have 25 recent analyst ratings on file.
- Company
- GoodRx Holdings Inc.
- Infosys Limited
- Price
- $2.63-0.94%
- $12.30-0.97%
- Market cap
- $890.7M
- $51.01B
- 1M return
- -7.07%
- -2.30%
- 1Y return
- -36.01%
- -32.71%
- Industry
- EDP Services
- EDP Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- News (4w)
- 3
- 11
- Recent ratings
- 25
- 25
GoodRx Holdings Inc.
GoodRx Holdings, Inc., through its subsidiaries, provides information and tools that enable consumers to compare prices and save on their prescription drug purchases in the United States. The company operates a price comparison platform that provides consumers with curated, geographically relevant prescription pricing, and access to negotiated prices through GoodRx codes that are used to save money on prescriptions across the United States. It also offers other healthcare products and services, including telehealth services. The company serves pharmacy benefit managers that manage formularies and prescription transactions, including establishing pricing between consumers and pharmacies. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.
Infosys Limited
Infosys Limited, together with its subsidiaries, provides consulting, technology, outsourcing, and next-generation digital services in North America, Europe, India, and internationally. It provides application development and management, independent validation, product engineering and management, infrastructure management, enterprise application management, and support and integration services. The company's products and platforms include Finacle, a core banking solution; Edge suite of products; Infosys Nia, an artificial intelligence platform; Infosys McCamish - an insurance platform; Wingspan, a customizable learning platform; Stater mortgage servicing platform; Panaya automation suite; and Skava, an e-commerce suite. The company serves clients in the financial services and insurance, life sciences and healthcare, manufacturing, retail, consumer packaged goods and logistics, hi-tech, communications, telecom OEM, media, energy, utilities, resources, services, and other industries. It has collaboration agreements with Rolls-Royce, BP plc, Newmont Corporation, RXR Realty, Majesco Limited, and Centre for Accessibility Australia. The company was formerly known as Infosys Technologies Limited and changed its name to Infosys Limited in June 2011. Infosys Limited was incorporated in 1981 and is headquartered in Bengaluru, India.
Latest GDRX
- Director Hirsch Douglas Joseph was granted 4,642 shares, increasing direct ownership by 2% to 247,502 units (SEC Form 4)
- Director Bruehlman Ronald E was granted 4,642 shares, increasing direct ownership by 4% to 133,918 units (SEC Form 4)
- GoodRx Launches GoodRx Companion, a New Subscription Designed to Lower Everyday Healthcare Costs
- Chief Accounting Officer Chan Thomas (Tc) converted options into 5,575 shares and covered exercise/tax liability with 2,838 shares, increasing direct ownership by 274% to 3,737 units (SEC Form 4)
- Officer Mcginnis Christopher A covered exercise/tax liability with 19,726 shares and converted options into 44,779 shares, increasing direct ownership by 16% to 177,616 units (SEC Form 4)
- SEC Form 144 filed by GoodRx Holdings Inc.
- SEC Form 4 filed by Chief Accounting Officer Chan Thomas (Tc)
- SEC Form 10-Q filed by GoodRx Holdings Inc.
- GoodRx Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- GoodRx Reports First Quarter 2026 Results
Latest INFY
- Infosys and LTA Launch AI-Driven Match and Fan Experiences at the HSBC Championships, and Beyond
- NICE Actimize X-Sight Enterprise Cloud Solutions Selected by DNB Norway to Transform its Fraud and Financial Crime Operations
- Infosys Expands Strategic Collaboration with DNB Bank ASA to Modernize Financial Crime Operations
- Infosys and Handelsblatt Media Group Unveil AI-Powered Editorial Engine to Enhance Storytelling and Enrich Reader Experience
- SEC Form 6-K filed by Infosys Limited
- SEC Form 6-K filed by Infosys Limited
- SEC Form 6-K filed by Infosys Limited
- Chief Financial Officer Sanghrajka Jayesh sold $5,665,250 worth of Indian Equity Shares (5,191 units at $1,091.36), decreasing direct ownership by 3% to 180,471 units (SEC Form 4)
- SEC Form 6-K filed by Infosys Limited
- Chief Human Resources Officer Mathew Shaji sold $807,606 worth of Indian Equity Shares (740 units at $1,091.36), decreasing direct ownership by 0.23% to 317,561 units (SEC Form 4)